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INTRODUCTION
Endometriosis is a benign gynecologic condition
characterized by presence of endometriotic tissue
outside the uterine cavity. Chronic pelvic pain and
infertility are two of its most common symptoms.
Endometriosis is commonly found and affects
about 5-10 % reproductive age women and more
than 30% infertile women.1-4
Genetics study in endometriosis is attracting re-
searchers in recent years. One of interest is poly-
morphism in progesterone receptor gene. Proges-
terone is a potent antagonist of estrogen-mediated-
proliferation in endometrium and plays an impor-
tant role in pathogenesis of endometriosis. Proges-
terone regulates this crusial function by its two
isoform, A and B, which are expressed by one
single gene located in chromosome 11q22-q23. PR-
A is commonly found in endometrial stroma while
PR-B in glandular which function by inducing cell
apoptosis and secretoric change, repectively. PR-B
acts as strong transcription activator to proges-
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Objective: To identify relationship between progesterone receptor
gene polymorphism promoter region +331G/A with the risk of
endometriosis.
Method: An observational case-control study. Population are wo-
men with endometriosis and/or adenomyosis who have been per-
formed laparotomy/laparoscopy at Obstetrics and Gynecology
Department Dr. Mohammad Hoesin General Hospital Palembang,
January-November 2013. Subjects fulfilled inclusion criteria, given
informed consent and performed blood sampling continued by PCR-
RFLP. Results were divided into A/A genotype (homozygote mu-
tant), G/A (heterozygote mutant), and G/G (homozygote wild type).
Data were analyzed by SPSS 21.0 version.
Result: PCR-RFLP results for+331G/A genotype were 26 (54.1%) in
case group and 14 (26.4%) in control. +331A/A genotype was not
found in both groups. There was significant increase risk of endo-
metriosis in women carrying genotype +331G/A to those with geno-
type +331G/G with OR 3.29 (p<0.05).
Conclusion: Polymorphism on progesterone receptor gene
+331G/A increases risk of endometriosis in Malay population in
Indonesia. Compared to previous studies, there is interesting finding
that polymorphic alels were found more commonly in our study.
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Abstrak
Tujuan: Mengetahui hubungan polimorfisme gen reseptor pro-
gesteron regio promoter +331G/A dengan risiko terjadinya endo-metriosis.
Metode: Sebuah studi kasus kontrol observasional dengan populasiperempuan penderita endometriosis dan/atau adenomiosis yang
dioperasi laparotomi/laparoskopi di Bagian Obstetrik dan Ginekologi
RSUP Dr. Mohammad Hoesin Palembang dari Januari sampai Novem-ber 2013. Subjek yang memenuhi kriteria inklusi, dilberikan informed
consent selanjutnya dilakukan pengambilan darah dilanjutkan peme-riksaan PCR-RFLP. Hasil pemeriksaan dibagi menjadi genotif A/A
(mutan heterozigot), G/A (mutan homozigot), dan G/G (wild type).
Analisis data menggunakan program SPSS versi 21.0
Hasil: l PCR-RFLP didapat genotif +331G/A sebanyak 26 (54,1%) pada
kasus dan 14 (26,4%) pada kontrol. Pada kedua kelompok genotif+331A/A tidak ditemukan. Terdapat peningkatan risiko endometriosis
pada perempuan dengan genotif +331G/A dibanding +331G/G denganrasio odd 3,29 (p<0,05).
Kesimpulan: Polimorfisme pada gen reseptor progesteron +331G/Ameningkatkan risiko endometriosis pada populasi ras Melayu di
Indonesia. Dibandingkan penelitian terdahulu, menarik mengetahui
alel polimorfik ditemukan dalam jumlah yang banyak pada studi ini.
[Maj Obstet Ginekol Indones 2016; 1: 52-56]
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terone target genes, while PR-A is a dominat
transrepressor of PR-B and ER-α activity anti-
proliferative effect of progesterone depends on
balance of these two isoforms.3,5-8
McDonnel, et al.9 found the mechanism of which
PR-A inhibits PR-B transcription activity by com-
petitive inhibition to general transcription factor of
mineralocorticoid receptor. While in non trans-
criptionally active cells, PR-A functions as glucocor-
ticoid inhibitors, PR-B, and androgen receptor.
Thus, repression of transcription activity of estro-
gen receptor depends on PR-A expression.10-12
Functional polymorphism at promoter region
+331G/A of receptor progesterone gene (rs108
95068), by adding TATA box the transcription start
site, promotes production PR-B relative to PR-A.
Change in PR-A/PR-B ratio is believed to interfere
stromal differentiation and lead to progesterone
resistance. Thus, our hypothesis is that DNA poly-
morphism in progesterone receptor gene which in-
terferes PR-A/PR-B ratio increases risk of endo-
metriosis.13
METHODS
This was a case control study took place in Obstet-
rics and Gynecology Department and Microbiology
Laboratory Dr. Mohammad Hoesin Hospital Palem-
bang from Januari to November 2013.
Population were women with endometriosis
and/or adenomyosis who have been performed la-
parotomy or laparoscopy in Obstetrics and Gyne-
cology Department Dr. Mohammad Hoesin General
Hospital Palembang.
Inclusion criteria were those in age 13-45 years
and still have period. Endometriosis women who
were pregnant, having ovarian carcinoma and
myoma were excluded from the study. Controls
were patients who undergone laparotomy or la-
paroscopy for other reasons and proven not having
endometriosis and/or adenomyosis.
Blood samples were collected in EDTA tube and
refrigerated in maximum temperature of 4°C until
DNA extraction performed. Extraction was con-
ducted using Chelex-100 method with phosphate
buffer saline (PBS) pH 7.4; Safonin 0.5% in PBS;
and Chelex 20% in ddH2O pH 10.5.
DNA genome fragments were multiplied in vitro
using oligonucleotide amplification primer pair to
limit ampification area. We used 18pmol primer
Forward 5’-CACTCATGGGATCTGAGAATC-3’ and
18pmol reverse primer 5’-CACAAGTCCGGCACTT
GAGT-3’. PCR was performed using lab cycler (Sen-
squest).
Polymorphism G/A in progesterone receptor
promoter region +331 was detected from RFLP
(restriction fragment length polymorphism) using
retriction enzyme NlaIV.
PCR products with 330 bp length were digested
by 1.0 unit NlaIV (isoschizomerBspLI, fermentas)
with buffer reaction and incubated in 37°C tem-
perature for 180 minutes. Then 5μl compound was
poured into 2% polyacrylamide gel electrophoresis
(PAGE) containing ethidium-bromide, then con-
tinued with electophoresis and visualized under
ultra violet using Gel-Dov (BIO-RAD laboratories
USA). Results were then analyzed using Quantity
One software.
RESULTS
Within periods of January to November 2013, there
were 101 subjects, 48 in case group and 53 in con-
trol group.
Mean age in case group of this study was 35.8
years. It corresponded with data showed that
average age for endometriosis patients were 35-45
years. Patients in case group have significantly
lower BMI than in control. More than half patients
with endometriosis experienced infertility (52.1%),
while only 7.5% of control group having infertility,
p<0.001.
Figure 1. Visualization Result after pcr-RFLP
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Table 1. Subject Sosiodemographic Characteristic
Characteristic
Case Control
pΔ % Δ %
Mean age (year) 35,8 28,11 <0.001
Parity
Nulliparous 33 68.8 24 9.4
Primigravid 7 14.6 24 45.3 <0.001
Multigravid 8 16.7 24 45.3
Mean BMI 22.96 25.47 0.003
Etnic group
South Sumatra 37 77.1 39 73.6
Jawa 8 16.7 10 18.9
Minang 1 2.1 2 3.8 0.358
Cina 2 4.2 0 0
Others 0 0 2 3.8
Marital status
Married 44 91.7 50 94.3 0.597Unmarried 4 8.3 3 5.7
Abortus history
 (+) 3 6.3 9 17.0 0.128 (-) 45 93.8 44 83.0
Hormonal
contraception
 (-) 36 75.0 41 77.4 0.255 (+) 12 25.0 12 22.6
Infertility
 (+) 25 52.1 4 7.5 <0.001 (-) 23 47.9 49 92.5
Smoking
 (+) 1 2.1 2 3.8 1.00 (-) 47 97.9 51 96.2
Family history
 (+) 3 6.3 5 9.4 0.718 (-) 45 93.8 48 90.6
Table 2. Distribution and Analysis of Progesterone
     Receptor Genotype
Genotype Case Control Total
Genotype
+331G/A 26 (54.1%) 14(26.4%) 40
Genotype
+331G/G 22 (45.8%) 39 (73.5%) 61
Total 48 53
OR: 3.292
(95% CI 1.43-
7.58), p<0,01
It can be said from the Table 2. that distribution
of mutant heterozygote genotype was found more
commonly in case group than control, p<0,01.
There was increase risk of endometriosis in wo-
men carrying progesterone receptor gene pro-
moter region +331G/A, with odd ratio 3.29 (95%
CI.43-7.58). Homozigote mutant genotype
(+331A/A) was not found in either group. Maybe
because limitation of number of subjects studied.
We then further analyzed relationship between
these two genotypes found in case groups with
other variables such endometriosis level, infertility,
and dysmenorhae. Correlation value between
genotype +331G/A and endometriosis level based
on ASRM was weak (0.27) with p>0.05 (Table 3).
Genotype +331G/A had also weak correlation with
dysmenorhae level, r 0.32 with p>0.05.14
Table 3. Distribution and Correlation Test between Genotypes and ASRM Endometriosis Level, and Genotypes with
     Dysmenorrhea Level in Case Group
Genotype Endometriosis level Dysmenorrhae level
I II III IV Total No pain Mild Moderate Severe Total
+331 G/A 1
4.5%
6
27.3%
6
27.3%
9
40.9%
22 4
15.3%
6
23.0%
8
30.7%
8
30.7%
26
+331 G/G 0
0.0%
4
19.0%
3
14.3%
14
66.7%
21 1
4.5%
1
4.5%
10
45.5%
10
45.5%
22
Total*
(%)
1 10 9 23 43
p= 0.33
r=0.27
5 2 23 18 48
p=0.14
r=0.32
*five adenomyosis only patients were not included
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DISCUSSION
There was significant age difference between case
and control group. This can be explained because
most subjects in control group were primiparous
where as the others were mostly women who
seeking for help after years of infertility. More than
half of case group were infertile. This finding was
along with the fact that endometriosis is one of
commonest cause of infertility.15
Some previous researchers reported of specific
group of women with tall and thin posture, short
ovulatoar cycle, and heavy menstrual bleeding as
to be "endometriosis phenotype". Women with
normal BMI tend to have more regular cycle than
those with higher BMI. From our findings, BMI
average in case group was significantly lower than
those in control group.
We also find in this study that presence of
+331G/A genotype increased the risk of endo-
metriosis with OR 3.29. While correlation of this
genotype with the ASRM level and dysmenorrhea
score was weak. Limitation of sample size and con-
secutive sampling methods were rationale of this
result.16
Gentilini et al.17 showed that this +331G/A po-
lymorphic gene increased risk for deep infiltrating
endometriosis with high invasive potential. It was
assumed that PR-B, with a nontranscriptional
mechanism, provokes cell development through in-
teraction with estrogen receptor and stimulates
Src/P21ras/ERK pathway. In investigating proges-
terone receptor on uterine myoma, Renner, et al.14
found that +331G/A genotype was related to endo-
metriosis incidence in myoma patients, which
means this genotype was found more common in
myoma patients having endometriosis.
De Vivo, et al.18 stated that progesterone recep-
tor gene polymorphism enhanced risk for endo-
metrial cancer by increasing PR-B receptor ex-
presssion.
This polymorphism was not related to cell abili-
ty to implant on ectopic sites but rather enabling
cell invasiveness by altering PR-A and PR-B
balance.
Different from those findings, Kaam, et al.13 de-
tected that +331A allele reduced risk of deep infil-
trating endometriosis and adenomyosis. From our
concideration, this result might be bias since allele
+331A only found in 2 subjects. It was also re-
ported from this study that ovarian ca patients did
not show increase on +331A allele significantly.
Berchuck, et al.11 reported lessen endometriosis
risk on +331A variant allele in women participat-
ing in the study of ovarian carcinoma. Treloar, et
al.19 found there was no relationship between
endometriosis risk with this variant.
Difference on study results were probably from
different sample size, population and demography
thus evoked variations in polymorphism pattern
reported. In this study, conducted in Indonesia, we
assumed to represented Malay population in Indo-
nesia. On our best knowledge, this study was the
first taken place in Indonesia. Previous researchers
in different countries and etnic group reported
various results. As we know, single nucleotide
polymorphism is an inherited form and the inci-
dence will be different among races.20-24
From this study we can conclude an interesting
fact that polymorphism frequency in progesterone
receptor gene promoter region +331G/A were
found frequently in subjects, 54.1% in case group
and 26.4% in control. Remembering that polymor-
phism is variable among groups and places, this
study took place in Sumatera Selatan Indonesia re-
vealed an attracting result.
Limitation of this study is that we did not ana-
lyzed progesterone receptor gene expression in
endometriotic tissues. This gene expression exami-
nation is crucial to see how significant genotype
polymorphism on tissue level, and to evaluate fac-
tors contributing to this.
CONCLUSION
Polymorphism on progesterone receptor gene pro-
moter region +331G/A has significant relation with
endometriosis. There is significant increase risk of
endometriosis on Malay population in Indonesia
having +331G/A gene compared to +331G/G gene.
While endometriosis level based on ASRM as well
as dysmenorrhea level are on weak correlation
with this gene polymorphism.
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